DJIA 17,533.62 -156.24 -0.88%
NASDAQ 5,097.20 -31.08 -0.61%
S&P 500 2,091.26 -12.58 -0.60%
market minute promo

Exelixis (NASDAQ: EXEL)

6.09 0.36 (6.28%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EXEL $6.09 6.28%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.77
Previous Close $5.73
Daily Range $5.76 - $6.31
52-Week Range $1.26 - $6.38
Market Cap $1.2B
P/E Ratio -4.90
Dividend (Yield) $0.00 (0.0%)
Volume 5,447,862
Average Daily Volume 8,134,729
Current FY EPS -$0.79

Sector

Healthcare

Industry

Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website: http://www.exelixis.com/

News & Commentary

3 Biotech Stocks That Could Double Before 2016

Here is a look at three small-cap biotech stocks with the potential to double within the next six months.

What to Expect from Exelixis (EXEL) This Earnings Season? (revised) - Analyst Blog

Can the Rally in Exelixis (EXEL) Shares Continue? - Tale of the Tape

What to Expect from Exelixis (EXEL) This Earnings Season? - Analyst Blog

Exelixis: A Buyout Target In The Making

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceu

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceuticals and Exelixis - Press Releases

Exelixis (EXEL) Stock Falls on Upsized Secondary Offering

Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog

Pre-Market Most Active for Jul 24, 2015 : EXEL, T, AMZN, BIIB, ITEK, FB, STM, QQQ, NOK, UN, ALU, CI

Pre-Market Most Active for Jul 24, 2015 : EXEL, T, AMZN, BIIB, ITEK, FB, STM, QQQ, NOK, UN, ALU, CI

Exelixis Prices 25M Share Offering @$5.40/Share

See More EXEL News...

EXEL's Top Competitors

EXEL $6.09 (6.28%)
Current stock: EXEL
TMO $138.06 (-1.05%)
Current stock: TMO
ILMN $215.89 (-1.55%)
Current stock: ILMN
WAT $133.27 (-0.16%)
Current stock: WAT